Skip to main content
Log in

Granulocyte response to oxidized FMLP

Evidence for partial inactivation of FMLP

  • Original Articles
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

We prepared FMoxLP by oxidation of FMLP and evaluated its ability to trigger a variety of granulocyte responses. FMoxLP was found to depolarize granulocyte membranes; increase granulocyte oxygen consumption, superoxide production, and hydrogen peroxide production; compete with FMLP for binding to granulocytes; and stimulate granulocyte chemotaxis. Against all of these granulocyte functions, FMoxLP was considerably less potent than the parent FMLP. When luminol-dependent-granulocyte chemiluminescence (CL) was studied, FMoxLP was observed to be a more potent stimulus of this response than FMLP. This increased CL activity of FMoxLP may be related to nonoxidative burst mechanisms. Our results indicate that FMoxLP retains a significant amount of the biological activity of FMLP (albeit in general less potent). The biological importance of the observed activities of FMoxLP must await further investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Clark, R. A. 1983. Extracellular effects of the myeloperoxidase-hydrogen peroxide-halide system.In Advances in Inflammation Research. G. Weissman, editor. Raven Press, New York. 107–146.

    Google Scholar 

  2. Jasin, H. E. 1983. Generation of IgG aggregates by the myeloperoxidase-hydrogen peroxide system.J. Immunol. 130:1918–1923.

    Google Scholar 

  3. Tsan, M. F., andDenison, R. C. 1981. Oxidation of N-formyl methionyl chemotactic peptide by human neutrophils.J. Immunol. 126:1387–1389.

    Google Scholar 

  4. Clark, R. A., andSzot, S. 1982. Chemotactic factor inactivation by stimulated human neutrophils mediated by myeloperoxidase-catalyzed methionine oxidation.J. Immunol. 128:1507–1513.

    Google Scholar 

  5. Williams, L. T., Snyderman, R., Pike, M. C., andLefkowite, R. J. 1977. Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes.Proc. Natl. Acad. Sci. U.S.A. 74:1204–1208.

    Google Scholar 

  6. Jones, G. S., Van Dyke, K., andCastranova, V. 1981. Transmembrane potential changes associated with superoxide release from human granulocytes.J. Cell. Physiol. 106:75–83.

    Google Scholar 

  7. Van Dyke, K., Peden, D., Van Dyke, C, Jones, G., Castranova, V., andMa, J. 1982. Inhibition by nonsteroidal antiinflammatory drugs of luminol dependent human granulocyte chemiluminescence and [3H]FMLP binding.Inflammation 6:113–125.

    Google Scholar 

  8. Jones, G. S., Van Dyke, K., andCastranova, V. 1980. Purification of human granulocytes by centrifugal elutriation and measurement of transmembrane potential.J. Cell. Physiol. 104:425–431.

    Google Scholar 

  9. Van Dyke, K., Van Dyke, C., Udeinya, J., Brister, C, andWilson, M. 1979. A new screening system based on chemiluminescence produced from human cells (granulocytes). Clin. Chem.25:1655–1661.

    Google Scholar 

  10. Root, R. K., Metcalf, J., Oshino, N., andChance, B. 1975. H2O2 release from human granulocytes during phagocytosis.J. Clin. Invest. 55:945–955.

    Google Scholar 

  11. Lane, T. A., Lamkin, G. C., andWindle, B. E. 1981. Phagocytosis-induced modulation of human neutrophil chemotaxis receptors.Blood 58:228–236.

    Google Scholar 

  12. Nelson, R. D., McCormack, R. T., andFiegel, V. D. 1978. Chemotaxis of human leukocytes under agarose.In Leukocyte Chemotaxis. P. G. Quie, editor. Raven Press, New York. 25–42.

    Google Scholar 

  13. Gilbertsen, R. B., Carter, G. W., andQuinn, D. J. 1980. Effects of F-Met-Leu-Phe and zymosan-activated serum on rat neutrophils in vivo.J. Reticuleondothel. Soc. 27:485–494.

    Google Scholar 

  14. Duncan, D. B. 1975.T-Tests and intervals for comparisons suggested by the data.Biometrics 31:339–359.

    Google Scholar 

  15. Clark, R. A., Szot, S., Venkatasubramanian, K., andSchiffman, E. 1980. Chemotactic factor inactivation by myeloperoxidase-mediated oxidation of methionine.J. Immunol. 124:2020–2026.

    Google Scholar 

  16. Snyderman, R., andGoetzl, E. J. 1981. Molecular and cellular mechanisms of leukocyte chemotaxis.Science 213:830–837.

    Google Scholar 

  17. Van Dyke, K., Matamoros, M, Van Dyke, C. J., andCastranova, V. 1983. Calcium ionophore-stimulated chemiluminescence (CL) from human granulocytes: Evidence that A23187-induced chemiluminescence originates from arachidonic acid metabolism.Microchemical J. 28:568–579.

    Google Scholar 

  18. Van Dyke, K., Castranova, V., andVan Dyke, C. J. 1983. Antiinflammatory drug effects on luminol-dependent chemiluminescence (CL) from human granulocytes stimulated by Ca++ ionophore (A23187) and by reduced or oxidized FMLP.Fed. Proc. 42:698.

    Google Scholar 

  19. Freer, R. J., Day, A. R., Raddino, J. A., Schiffman, E., Aswanikumar, S., Showell, H. J., andBecker, E. L. 1980. Further studies on the structural requirements for synthetic peptide chemoattractants.Biochemistry 19:2404–2410.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van Dyke, K., Castranova, V., Van Dyke, C.J. et al. Granulocyte response to oxidized FMLP. Inflammation 8, 87–99 (1984). https://doi.org/10.1007/BF00918356

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00918356

Keywords

Navigation